Trial Profile
An Evaluation of the Pharmacokinetics and Safety of a Single Dose of UT-15C SR (Treprostinil Diethanolamine) in Subjects With Renal Impairment.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Aug 2014
Price :
$35
*
At a glance
- Drugs Treprostinil (Primary)
- Indications Peripheral ischaemia; Pulmonary arterial hypertension
- Focus Pharmacokinetics
- Sponsors United Therapeutics Corporation
- 08 Aug 2014 New trial record
- 08 Dec 2010